Bet***hon

Therapy Area Head: CKAD · Full-time Nov 2023 to Present · 1 yr 3 mos

Bildung

Seton Hall University School of Law

Seton Hall University School of Law J.D., Concentration in Intellectual Property University of North Carolina at Chapel Hill B.S., Biomaterials

Fähigkeiten:

Oncology Endorsed by 6 colleagues at The Janssen Pharmaceutical Companies of Johnson & Johnson Endorsed by 9 people who know the skill 24 endorsements Clinical Operations 3 endorsements

Berufserfahrung:

Therapy Area Head: CKAD Novo Nordisk · Full-time Nov 2023 to Present · 1 yr 3 mos Senior Director, Head of Feasibility Center of Excellence The Janssen Pharmaceutical Companies of Johnson & Johnson Jul 2021 to Nov 2023 · 2 yrs 5 mos Johnson & Johnson 14 yrs 4 mos Global Feasibility TA Head, Oncology Mar 2019 to Jul 2021 · 2 yrs 5 mos Director, Strategic Account Lead Oct 2016 to Mar 2019 · 2 yrs 6 mos Associate Director, TCSM Oncology Oct 2010 to Oct 2016 · 6 yrs 1 mo Clinical Operations Associate Roche 2004 to 2007 · 3 yrs

KI-Lebenslaufanalyse

Kandidaten-Intelligenzbericht

KI-gestützte Analyse aus der Perspektive eines US-Einstellungsdirektors — Bewertung von Karrierekontinuität, Wachstumstrajektorie und Rollenpassung.

Karrierekontinuität und Risikobewertung

Employment GapMedium

There is a public gap from Roche (2004-2007) to the next listed role (2010) of approximately 3 years. A brief explanation or documentation would help clarify uninterrupted career progression.

Industry ConsistencyHigh

All roles are within pharma/biotech (Roche, Janssen/Johnson & Johnson, Novo Nordisk), indicating strong industry alignment and reducing onboarding risk in global pharma environments.

Tenure StabilityLow

Demonstrated long tenures with progressive responsibilities at Janssen (2010-2023) and a subsequent move to Novo Nordisk; overall stability is strong.

Education-Career MatchMedium

Education from Seton Hall University School of Law is not a direct clinical operations credential; it may add governance/regulatory value but is not a typical operational qualification.

Karrierewachstumskurve

Clinical Operations Associate Entry
Roche
2004-2007
Gap in employment Gap
2007-2010
Associate Director, TCSM Oncology ↑ Befördert
Johnson & Johnson (Janssen)
Oct 2010 - Oct 2016
Director, Strategic Account Lead ↑ Befördert
Johnson & Johnson (Janssen)
Oct 2016 - Mar 2019
Global Feasibility TA Head, Oncology ↑ Befördert
Johnson & Johnson (Janssen)
Mar 2019 - Jul 2021
Senior Director, Head of Feasibility Center of Excellence ↑ Befördert
The Janssen Pharmaceutical Companies of Johnson & Johnson
Jul 2021 - Nov 2023
Therapy Area Head: CKAD ↑ Befördert
Novo Nordisk
Nov 2023 - Present
Bewertung:Beth shows a clear upward trajectory within oncology operations and feasibility, culminating in a global therapy-area leadership role. The early career gap is a mitigated risk with long tenure elsewhere in pharma; overall she appears ready for higher-level global leadership roles that require cross-functional execution and strategic oversight, subject to alignment with compensation and regulatory expectations.

Bestpassende Rollen (Top 5)

1

Global Head of Clinical Operations, Oncology92% Passung

Demonstrated global leadership across oncology operations and feasibility with P&L oversight and cross-functional governance; aligns with her track record of multi-site leadership and strategic operational delivery.

2

Head of Feasibility Center of Excellence (Global)90% Passung

Previous role as Head of Feasibility CoE and Global Feasibility TA Head; strong fit for leading the global feasibility function in a pharma/biotech setting.

3

Vice President / SVP, Global Clinical Operations Strategy (TCSM)86% Passung

Past experience in TCSM and strategic accounts, with progressive leadership; suited for a strategy-focused global ops executive role.

4

Chief Operating Officer, Oncology-focused Biotech82% Passung

Broad operations leadership with oncology focus, capable of shaping end-to-end operations, scaling capabilities, and cross-functional performance.

5

Global Therapy Area Lead, Oncology (CKAD) / Senior Director-Level Head78% Passung

Continuity in therapy-area leadership at a top pharma; valuable for organizations seeking a proven oncologic therapy leader with global exposure.

Erleben Sie AI Recruiter

Kostenlos starten. Lassen Sie Ihre Konkurrenten nicht den KI-Vorteil zuerst ergattern.

Schließen Sie sich über 10.000 Unternehmen an, die KI-gestützte Recruiting-Lösungen nutzen, um Ihren Einstellungsprozess zu automatisieren und 80% Zeitkosten zu sparen.

33% Rabatt, nur noch 48 Stunden!
Kostenlos AI testen

24/7 automatisierter Betrieb

KI-gestützte Kandidatenauswahl

Recruiting ohne geografische oder zeitliche Einschränkungen

Personalisierte intelligente Kommunikation

Automatisierte Bewertung des Kandidatenengagements

Ahmt Ihren Recruiting-Stil intelligent nach

4-monatige Geld-zurück-Garantie

Gewährleistet LinkedIn-Kontosicherheit